ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2178

Metabolic Osteoarthritis: Relation of Cardiovascular Disease and Diabetes to Knee Osteoarthritis

Laura Kuusalo1, David T. Felson2, Carrie Brown3, Cora E. Lewis4, James Torner5 and Tuhina Neogi2, 1University of Turku and Turku University Hospital, Turku, Finland, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Boston University School of Public Health, Boston, MA, 4University of Alabama Birmingham, Birmingham, AL, 5University of Iowa, Iowa City, IA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease, diabetes and osteoarthritis, Knee

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Osteoarthritis – Clinical Aspects Poster II: Observational and Epidemiological Studies

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Metabolic changes or low-grade inflammation related to cardiovascular disease (CVD) and diabetes have been hypothesized to contribute to the development of OA. Prior studies have demonstrated an association between diabetes and OA, and recognized OA as a risk factor for incident CVD. However, it remains unclear whether these associations are truly causal as they have not been confirmed in longitudinal cohort studies and may be explained by shared risk factors. The aim of the current study was therefore to examine the associations of pre-existing CVD and diabetes with incident knee OA.

Methods: The study sample consisted of Multicenter Osteoarthritis (MOST) Study participants. We used a self-administered modified Charlson comorbidity questionnaire to assess pre-existing CVD (heart attack, stroke, transient ischemic attack, heart or leg bypass surgery, treatment for heart failure) and diabetes in the participants at baseline. We assessed radiographic (ROA) and symptomatic (SxOA) knee OA at baseline and at 60-months follow-up. We defined ROA as Kellgren-Lawrence grade ≥ 2 on the knee radiograph, and SxOA as ROA and frequent knee pain in the same knee. While we primarily aimed to evaluate the effect of CVD and diabetes on development of knee OA, we recognize that such comorbidities are often chronic and their effects on OA may have already occurred in these older study subjects prior to their study entry. This could result in depletion of susceptibles in a study of their effects on incident knee OA. Therefore, we evaluated both the cross-sectional and longitudinal relation of CVD and diabetes to prevalent and incident ROA and SxOA using logistic regression. We adjusted the models for age, sex, race, body mass index (BMI), history of knee injury/surgery, physical activity, and correlation between knees within each participant.

Results: We included 5929 knees of 3014 participants in the baseline cross-sectional analyses (mean±SD age 62.5±8.1, mean BMI 30.8±6.0, 60% Caucasian) and 2317 knees of 1181 participants free of knee OA at baseline in the longitudinal analyses (mean±SD age 60.7±7.7, mean±SD BMI 29.1±4.7, 59% Caucasian). In cross-sectional analyses, CVD and diabetes were not associated with ROA and SxOA (Table). In longitudinal analyses, we also found no association of CVD or diabetes with incident ROA or SxOA (Table).

Conclusion: Self-reported CVD and diabetes were not associated with prevalent or incident knee ROA or SxOA after adjustment for potential confounders. Although some of our analyses had limited precision, our results suggest that that these common comorbidities do not appear to contribute to development of knee OA. Specific factors that may contribute to a metabolic OA phenotype require further evaluation.


Disclosure: L. Kuusalo, None; D. T. Felson, None; C. Brown, None; C. E. Lewis, None; J. Torner, None; T. Neogi, None.

To cite this abstract in AMA style:

Kuusalo L, Felson DT, Brown C, Lewis CE, Torner J, Neogi T. Metabolic Osteoarthritis: Relation of Cardiovascular Disease and Diabetes to Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/metabolic-osteoarthritis-relation-of-cardiovascular-disease-and-diabetes-to-knee-osteoarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/metabolic-osteoarthritis-relation-of-cardiovascular-disease-and-diabetes-to-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology